ask="5.00"
ask_size="9000"
average_daily_volume="54577"
bid="2.61"
bid_size="100"
book_value="1.19"
change="+0.03"
change_from_200_day_moving_average="-1.23"
change_from_50_day_moving_average="-0.34"
change_from_52_week_high="-3.70"
change_From_52_week_low="0.20"
change_in_percent="+1.08%"
close="2.82"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.90"
ebitda="-15.74M"
eps_estimate_current_year="-3.71"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.81"
ex_dividend_date="N/A"
float_shares="5652000"
high="2.93"
high_52_weeks="6.52"
last_trade_date="2/10/2017"
last_trade_price="2.82"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.73"
low_52_weeks="2.62"
market_capitalization="17.75M"
moving_average_200_day="4.05"
moving_average_50_day="3.16"
name="MabVax Therapeutics Holdings
I"
notes="N/A"
one_year_target_price="18.00"
open="2.80"
pe_ratio="N/A"
peg_ratio="-0.01"
percent_change_from_200_day_moving_average="-30.35%"
percent_change_from_50_day_moving_average="-10.87%"
percent_change_from_52_week_high="-56.74%"
percent_change_from_52_week_low="+7.63%"
previous_close="2.79"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.34"
price_per_sales="19.40"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="7.95"
stock_exchange="NCM"
symbol="MBVX"
volume="44411"
weeks_range_52="2.62 - 6.52"
